LD-2 disclosure · 2nd Quarter - Report
ORGANOGENESIS INC.
Client
- Name
- ORGANOGENESIS INC.
- Description
- Biotech company
- Location
- Massachusetts · United States of America
Registrant
- Description
- Law firm
- Location
- Washington, District of Columbia, United States of America
Lobbying activities
2 issuesMedicare/Medicaid
Medicare reimbursement policy for chronic wound healing products, including Local Coverage Determinations and Discarded Products policy Physician Fee Schedule regulations regarding reimbursement for chronic wound healing products (CY2026 and CY2027) Hospital Outpatient Prospective Payment System regulations regarding reimbursement for chronic wound healing products (CY2026 and CY2027) H.R. 5768 and S. 2561 (Skin Substitute Access and Payment Reform Act of 2025), entire bill H.R.6852 (Advanced Wound Care and Regenerative Medicine Access and Reform Act), entire bill
LobbyistsDAN RENBERG · OLIVER SPURGEON III · KELSEY GRISWOLD-BERGER · ELIZABETH HORNER · BLAKE THELANDER
TargetedSENATE · HOUSE OF REPRESENTATIVES · Centers For Medicare and Medicaid Services (CMS)
Health Issues
Food and Drug Administration policy on chronic wound healing products
LobbyistsDAN RENBERG